Mon, Dec 22, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Amida Capital Management adds senior staffers

Monday, March 05, 2012
Opalesque Industry Update:Amida Capital Management II, LLC, a New York based investment manager specializing in relative value and convertible arbitrage, has expanded its investment platform and appointed Sudeep Duttaroy as a Portfolio Manager and Raymond Lam, CFA as a Credit Analyst. Messrs. Duttaroy and Lam will report to David Rich, Amida’s Founder and Chief Investment Officer.

“Sudeep and Ray, long-term industry colleagues, bring to Amida over fifteen years of combined experience in convertible markets. We are excited about the opportunities we currently see for the strategy and with the new additions we continue to build solid institutional quality platform and broaden our strong fundamental and quantitative research expertise."

“Properly managed convertible strategies have been consistent and less volatile performers than other alternative strategies, proving their ability to deliver upside participation while preserving capital. With the exit of many hedge fund participants from the market place in 2008 resulting in a larger segment of long-only funds, we believe that ample opportunities and demand for niche relative value managers like ourselves are present in today’s investment climate”, continued Mr. Rich.

Mr. Duttaroy and Mr. Lam join Amida from AM Investment Partners, where Mr. Duttaroy was a Portfolio Manager and Mr. Lam was a Senior Analyst.

Mr. Duttaroy graduated with a Bachelor of Arts in Computer Science from the University of Texas- Austin and a Master of Science in Financial Mathematics from the University of Chicago. Mr. Lam graduated with a Bachelor of Science in Electrical Engineering from Columbia University and a Master of Business Administration from New York University, both with honors.

Amida Partners

Press Release

BM

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  5. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for